Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Blood Cancer Journal
|
December 15, 2021
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, et al.
Leukemia Research
|
December 14, 2011
Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain
Blanca Sanchez-Gonzalez, F Javier Peñalver, Angeles Medina, et al.
Haematologica
|
April 26, 2014
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis
Santiago Montes-Moreno, Ana Batlle, Sonia González de Villambrosía, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2014
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial
Josep-Maria Ribera, Albert Oriol, Mireia Morgades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2024
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group
Beatriz Rey-Búa, Carlos Grande, José J Sánchez Blanco, et al.
Cancer Medicine
|
October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma
Ana Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Oncotarget
|
February 25, 2016
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker
Ana Batlle-López, Sonia González de Villambrosía, Mazorra Francisco, et al.
Leukemia & Lymphoma
|
March 23, 2002
Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma
Juan José Lahuerta, Carlos Grande, Joan Blade, et al.
Leukemia & Lymphoma
|
January 9, 2014
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients
Blanca Xicoy, Josep-Maria Ribera, Markus Müller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 24, 2017
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure
Ana Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Blood Cancer Journal
|
December 15, 2021
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, Catarina Maia, et al.
Leukemia Research
|
December 14, 2011
Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain
Blanca Sanchez-Gonzalez, F Javier Peñalver, Angeles Medina, et al.
Haematologica
|
April 26, 2014
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis
Santiago Montes-Moreno, Ana Batlle, Sonia González de Villambrosía, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2014
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial
Josep-Maria Ribera, Albert Oriol, Mireia Morgades, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2024
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group
Beatriz Rey-Búa, Carlos Grande, José J Sánchez Blanco, et al.
Cancer Medicine
|
October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma
Ana Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Oncotarget
|
February 25, 2016
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker
Ana Batlle-López, Sonia González de Villambrosía, Mazorra Francisco, et al.
Leukemia & Lymphoma
|
March 23, 2002
Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma
Juan José Lahuerta, Carlos Grande, Joan Blade, et al.
Leukemia & Lymphoma
|
January 9, 2014
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients
Blanca Xicoy, Josep-Maria Ribera, Markus Müller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 24, 2017
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure
Ana Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Page
of 10